Antibiotic resistance—the need for global solutions

[1]  E. Concia,et al.  New antibiotic development: barriers and opportunities , 2016 .

[2]  H. Goldbach,et al.  Antibiotics as part of the management of severe acute malnutrition. , 2013, The New England journal of medicine.

[3]  T. Zaoutis,et al.  Nontherapeutic Use of Antimicrobial Agents in Animal Agriculture: Implications for Pediatrics , 2013, Pediatrics.

[4]  Daniel J. Shapiro,et al.  Antibiotic prescribing for adults in ambulatory care in the USA, 2007-09. , 2014, The Journal of antimicrobial chemotherapy.

[5]  Arti Kapi.  The evolving threat of antimicrobial resistance: Options for action , 2014 .

[6]  Samir N. Patel,et al.  Linezolid resistance in Enterococcus faecium isolated in Ontario, Canada. , 2013, Diagnostic microbiology and infectious disease.

[7]  G. Greisen,et al.  Neonatal bloodstream infections in a pediatric hospital in Vietnam: a cohort study. , 2013, Journal of tropical pediatrics.

[8]  Herman Goossens,et al.  Effects of internet-based training on antibiotic prescribing rates for acute respiratory-tract infections: a multinational, cluster, randomised, factorial, controlled trial , 2013, The Lancet.

[9]  J. Tinoco,et al.  Virulence and antibiotic resistance of Enterococcus faecalis clinical isolates recovered from three states of Mexico. Detection of linezolid resistance. , 2013, Archives of medical research.

[10]  M. Lipsitch,et al.  Targeting Imperfect Vaccines against Drug-Resistance Determinants: A Strategy for Countering the Rise of Drug Resistance , 2013, PloS one.

[11]  Thomas Backhaus,et al.  Human Health Risk Assessment (HHRA) for Environmental Development and Transfer of Antibiotic Resistance , 2013, Environmental health perspectives.

[12]  C. Jernberg,et al.  Characterization of plasmid-mediated AmpC-producing E. coli from Swedish broilers and association with human clinical isolates. , 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[13]  James J. Collins,et al.  Silver Enhances Antibiotic Activity Against Gram-Negative Bacteria , 2013, Science Translational Medicine.

[14]  S. Karutha Pandian,et al.  Virulence and multidrug resistance patterns of Vibrio cholerae O1 isolates from diarrheal outbreaks of South India during 2006-2009. , 2013, Microbial drug resistance.

[15]  S. Ray,et al.  Clinical Use of Colistin Induces Cross-Resistance to Host Antimicrobials in Acinetobacter baumannii , 2013, mBio.

[16]  E. Diamadopoulos,et al.  Detection and fate of antibiotic resistant bacteria in wastewater treatment plants: a review. , 2013, Ecotoxicology and environmental safety.

[17]  J. Farrar,et al.  Providing Impetus, Tools, and Guidance to Strengthen National Capacity for Antimicrobial Stewardship in Viet Nam , 2013, PLoS medicine.

[18]  R. Hunt,et al.  Fecal Microbiota Transplantation for Clostridium difficile Infection: Systematic Review and Meta-Analysis , 2013, The American Journal of Gastroenterology.

[19]  David L. Smith,et al.  The changing epidemiology of methicillin-resistant Staphylococcus aureus in the United States: a national observational study. , 2013, American journal of epidemiology.

[20]  J. Dekker,et al.  Promising new assays and technologies for the diagnosis and management of infectious diseases. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  Julian Parkhill,et al.  A genomic portrait of the emergence, evolution, and global spread of a methicillin-resistant Staphylococcus aureus pandemic , 2013, Genome research.

[22]  J. Parkhill,et al.  Whole genome sequencing identifies zoonotic transmission of MRSA isolates with the novel mecA homologue mecC , 2013, EMBO molecular medicine.

[23]  E. Lingaas,et al.  Secular trends in nosocomial bloodstream infections: antibiotic-resistant bacteria increase the total burden of infection. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  W. Ko,et al.  Emerging resistance problems and future perspectives in pharmacotherapy for complicated urinary tract infections , 2013, Expert opinion on pharmacotherapy.

[25]  Richard Smith,et al.  The true cost of antimicrobial resistance , 2013, BMJ.

[26]  Michael Bell,et al.  Vital Signs: Carbapenem-Resistant Enterobacteriaceae , 2013, MMWR. Morbidity and mortality weekly report.

[27]  L. Price,et al.  Foodborne urinary tract infections: a new paradigm for antimicrobial-resistant foodborne illness , 2013, Front. Microbiol..

[28]  M. Bowen.  Antimicrobial stewardship: Time for change. , 2013, Equine veterinary journal.

[29]  Wendy R. Sanhai,et al.  A comprehensive regulatory framework to address the unmet need for new antibacterial treatments. , 2013, The Lancet. Infectious diseases.

[30]  J. Jacobs,et al.  Antimicrobial Resistance in Invasive Non-typhoid Salmonella from the Democratic Republic of the Congo: Emergence of Decreased Fluoroquinolone Susceptibility and Extended-spectrum Beta Lactamases , 2013, PLoS neglected tropical diseases.

[31]  A. Omrani,et al.  Prevalence of colistin and tigecycline resistance in Acinetobacter baumannii clinical isolates from 2 hospitals in Riyadh Region over a 2-year period. , 2013, Saudi medical journal.

[32]  Hugo Devlieger,et al.  Antibiotic Prescribing in DR Congo: A Knowledge, Attitude and Practice Survey among Medical Doctors and Students , 2013, PloS one.

[33]  J. Ziem,et al.  Susceptibility of bacterial etiological agents to commonly-used antimicrobial agents in children with sepsis at the Tamale Teaching Hospital , 2013, BMC Infectious Diseases.

[34]  D. Missiakas,et al.  Small molecule inhibitor of lipoteichoic acid synthesis is an antibiotic for Gram-positive bacteria , 2013, Proceedings of the National Academy of Sciences.

[35]  E. Brown.  Is the GAIN Act a turning point in new antibiotic discovery? , 2013, Canadian journal of microbiology.

[36]  E. Klein,et al.  Trends in Resistance to Carbapenems and Third-Generation Cephalosporins among Clinical Isolates of Klebsiella pneumoniae in the United States, 1999–2010 , 2013, Infection Control & Hospital Epidemiology.

[37]  H. Nepal,et al.  Bacteriological profile of neonatal septicemia cases and the antimicrobial resistance pattern in a tertiary care hospital of central Nepal , 2013 .

[38]  H. Goossens.  The Chennai declaration on antimicrobial resistance in India. , 2013, The Lancet. Infectious diseases.

[39]  Ichiro Kawachi,et al.  Behavioral economics: merging psychology and economics for lifestyle interventions. , 2013, American journal of preventive medicine.

[40]  H. Goossens,et al.  Amoxicillin for acute lower-respiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trial. , 2013, The Lancet. Infectious diseases.

[41]  M. Hilty,et al.  Extended-spectrum cephalosporin-resistant Gram-negative organisms in livestock: an emerging problem for human health? , 2013, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[42]  A. P. Williams,et al.  The role of the natural environment in the emergence of antibiotic resistance in gram-negative bacteria. , 2013, The Lancet. Infectious diseases.

[43]  I. Okeke,et al.  Cholera Outbreaks in Nigeria Are Associated with Multidrug Resistant Atypical El Tor and Non-O1/Non-O139 Vibrio cholerae , 2013, PLoS neglected tropical diseases.

[44]  B. Guerra,et al.  Salmonella enterica subsp. enterica producing VIM-1 carbapenemase isolated from livestock farms. , 2013, The Journal of antimicrobial chemotherapy.

[45]  C. Potera.  Phage Renaissance: New Hope against Antibiotic Resistance , 2013, Environmental health perspectives.

[46]  O. Minzi,et al.  Application of basic pharmacology and dispensing practice of antibiotics in accredited drug-dispensing outlets in Tanzania , 2013, Drug, healthcare and patient safety.

[47]  Céline Pulcini,et al.  How to educate prescribers in antimicrobial stewardship practices , 2013, Virulence.

[48]  M. Pfaller,et al.  Rapid detection of antibiotic-resistant organism carriage for infection prevention. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[49]  Jon Cohen,et al.  Infectious disease. Approval of novel TB drug celebrated--with restraint. , 2013, Science.

[50]  Alfonso Mendoza,et al.  Fueling Open-Source Drug Discovery: 177 Small-Molecule Leads against Tuberculosis , 2013, ChemMedChem.

[51]  J. Nieman,et al.  Discovery of a Novel Class of Boron-Based Antibacterials with Activity against Gram-Negative Bacteria , 2013, Antimicrobial Agents and Chemotherapy.

[52]  D. Shlaes.  New β‐lactam–β‐lactamase inhibitor combinations in clinical development , 2013, Annals of the New York Academy of Sciences.

[53]  Bernadette A. Thomas,et al.  Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[54]  A. Ghaffar,et al.  Access to medicines from a health system perspective , 2012, Health policy and planning.

[55]  Pedro M. Pereira,et al.  Inhibition of WTA Synthesis Blocks the Cooperative Action of PBPs and Sensitizes MRSA to β-Lactams , 2012, ACS chemical biology.

[56]  F. Ciccosanti,et al.  Applying proteomic technology to clinical virology , 2012, Clinical Microbiology and Infection.

[57]  G. Ehrlich,et al.  PCR Is Changing Clinical Diagnostics , 2013 .

[58]  S. Singh,et al.  The Chennai Declaration: a roadmap to tackle the challenge of antimicrobial resistance. , 2013, Indian journal of cancer.

[59]  Tong Zhang,et al.  Metagenomic insights into chlorination effects on microbial antibiotic resistance in drinking water. , 2013, Water Research.

[60]  A. Carattoli,et al.  High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality. , 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[61]  R. Humphries,et al.  The emerging problem of linezolid-resistant Staphylococcus. , 2013, The Journal of antimicrobial chemotherapy.

[62]  S. Kaufmann,et al.  Targeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccines , 2012, Medical Microbiology and Immunology.

[63]  Haruo Watanabe,et al.  Genetic characteristics of drug-resistant Vibrio cholerae O1 causing endemic cholera in Dhaka, 2006-2011. , 2012, Journal of medical microbiology.

[64]  P. Suwanwaree,et al.  Antibiotics Smart Use: a workable model for promoting the rational use of medicines in Thailand. , 2012, Bulletin of the World Health Organization.

[65]  V. Clifford,et al.  Community-acquired neonatal and infant sepsis in developing countries: efficacy of WHO's currently recommended antibiotics—systematic review and meta-analysis , 2012, Archives of Disease in Childhood.

[66]  G. Tomson,et al.  Community Acceptability and Adoption of Integrated Community Case Management in Uganda , 2012, The American journal of tropical medicine and hygiene.

[67]  S. Cousens,et al.  Integrated Community Case Management of Fever in Children under Five Using Rapid Diagnostic Tests and Respiratory Rate Counting: A Multi-Country Cluster Randomized Trial , 2012, The American journal of tropical medicine and hygiene.

[68]  Oana Falup-Pecurariu,et al.  Lessons learnt after the introduction of the seven valent-pneumococcal conjugate vaccine toward broader spectrum conjugate vaccines. , 2012, Biomedical journal.

[69]  A. Klančnik,et al.  Epigallocatechin gallate as a modulator of Campylobacter resistance to macrolide antibiotics. , 2012, International journal of antimicrobial agents.

[70]  Anthony M. Smith,et al.  Salmonella Typhi in the Democratic Republic of the Congo: Fluoroquinolone Decreased Susceptibility on the Rise , 2012, PLoS neglected tropical diseases.

[71]  Z. Bhutta,et al.  Epidemiology, clinical presentation, and patterns of drug resistance of Salmonella Typhi in Karachi, Pakistan. , 2012, Journal of infection in developing countries.

[72]  M. Oleksiewicz,et al.  Anti-bacterial monoclonal antibodies: back to the future? , 2012, Archives of biochemistry and biophysics.

[73]  J. Bartlett,et al.  White paper: recommendations on the conduct of superiority and organism-specific clinical trials of antibacterial agents for the treatment of infections caused by drug-resistant bacterial pathogens. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[74]  B. Criel,et al.  Do guidelines influence the implementation of health programs? — Uganda’s experience , 2012, Implementation Science.

[75]  F. Guillén-Grima,et al.  Clinical and economic evaluation of the impact of rapid microbiological diagnostic testing. , 2012, The Journal of infection.

[76]  R. Rappuoli,et al.  Vaccines and antibiotic resistance. , 2012, Current opinion in microbiology.

[77]  R. Sawyer,et al.  Aggressive versus conservative initiation of antimicrobial treatment in critically ill surgical patients with suspected intensive-care-unit-acquired infection: a quasi-experimental, before and after observational cohort study. , 2012, The Lancet. Infectious diseases.

[78]  C. Gomes,et al.  Transferable mechanisms of quinolone resistance. , 2012, International journal of antimicrobial agents.

[79]  T. Khadem,et al.  Antimicrobial Stewardship: A Matter of Process or Outcome? , 2012, Pharmacotherapy.

[80]  J. Bérdy.  Thoughts and facts about antibiotics: Where we are now and where we are heading , 2012, The Journal of Antibiotics.

[81]  Roger G. Linington,et al.  Chemical Inhibitors of the Type Three Secretion System: Disarming Bacterial Pathogens , 2012, Antimicrobial Agents and Chemotherapy.

[82]  Yongyue Wei,et al.  Comparison of the prevalence and changing resistance to nalidixic acid and ciprofloxacin of Shigella between Europe-America and Asia-Africa from 1998 to 2009. , 2012, International journal of antimicrobial agents.

[83]  N. Woodford,et al.  Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly? , 2012, The Journal of antimicrobial chemotherapy.

[84]  Nicholas A Feasey,et al.  Invasive non-typhoidal salmonella disease: an emerging and neglected tropical disease in Africa , 2012, The Lancet.

[85]  J. Scribante,et al.  Antibiotic prescription practices and their relationship to outcome in South Africa: findings of the prevalence of infection in South African intensive care units (PISA) study. , 2012, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[86]  Jamie Perin,et al.  Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000 , 2012, The Lancet.

[87]  I. Gould,et al.  Trends in Staphylococcus aureus bacteraemia and impacts of infection control practices including universal MRSA admission screening in a hospital in Scotland, 2006–2010: retrospective cohort study and time-series intervention analysis , 2012, BMJ Open.

[88]  J. Mahanta,et al.  Emergence of classical ctxB genotype 1 and tetracycline resistant strains of Vibrio cholerae O1 El Tor in Assam, India. , 2012, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[89]  A. Zaidi,et al.  Tropical bacterial gastrointestinal infections. , 2012, Infectious disease clinics of North America.

[90]  N. Goel,et al.  A ten year analysis of multi-drug resistant blood stream infections caused by Escherichia coli & Klebsiella pneumoniae in a tertiary care hospital , 2012, The Indian journal of medical research.

[91]  M. Falagas,et al.  Impact of Antibiotic MIC on Infection Outcome in Patients with Susceptible Gram-Negative Bacteria: a Systematic Review and Meta-Analysis , 2012, Antimicrobial Agents and Chemotherapy.

[92]  S. Jenks.  New NIH center broadens scope of translational research. , 2012, Journal of the National Cancer Institute.

[93]  S. Michie,et al.  Evaluation of the national Cleanyourhands campaign to reduce Staphylococcus aureus bacteraemia and Clostridium difficile infection in hospitals in England and Wales by improved hand hygiene: four year, prospective, ecological, interrupted time series study , 2012, BMJ : British Medical Journal.

[94]  Fang Wang,et al.  Overprescribing in China, driven by financial incentives, results in very high use of antibiotics, injections, and corticosteroids. , 2012, Health affairs.

[95]  V. Miriagou,et al.  Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[96]  Janice M. Reichert,et al.  Marketed therapeutic antibodies compendium , 2012, mAbs.

[97]  A. So,et al.  3Rs for innovating novel antibiotics: sharing resources, risks, and rewards , 2012, BMJ : British Medical Journal.

[98]  D. Heymann,et al.  Challenges of drug resistance in the developing world , 2012, BMJ : British Medical Journal.

[99]  Rebecca Guy,et al.  Mandatory surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in England: the first 10 years. , 2012, The Journal of antimicrobial chemotherapy.

[100]  S. Pagel,et al.  Use of antimicrobial agents in livestock. , 2012, Revue scientifique et technique.

[101]  H. Goossens,et al.  Human use of antimicrobial agents. , 2012, Revue scientifique et technique.

[102]  B. West,et al.  Sensitivity pattern among bacterial isolates in neonatal septicaemia in port Harcourt , 2012, Annals of Clinical Microbiology and Antimicrobials.

[103]  M. Millar.  Constraining the use of antibiotics: applying Scanlon's contractualism , 2012, Journal of Medical Ethics.

[104]  Robert E. W. Hancock,et al.  Modulating immunity as a therapy for bacterial infections , 2012, Nature Reviews Microbiology.

[105]  E. Blozik,et al.  Telemedicine can help to ensure that patients receive timely medical care , 2012, Journal of telemedicine and telecare.

[106]  Marion Ritzi-Lehnert,et al.  Development of chip-compatible sample preparation for diagnosis of infectious diseases , 2012, Expert review of molecular diagnostics.

[107]  Robert J. Williams,et al.  Collaborative approaches to anticancer drug discovery and development: a Cancer Research UK perspective. , 2012, Drug discovery today.

[108]  D. Hamer,et al.  Quality and safety of integrated community case management of malaria using rapid diagnostic tests and pneumonia by community health workers , 2012, Pathogens and global health.

[109]  S. Dasgupta,et al.  Profile of Neonatal Septicaemia at a District-level Sick Newborn Care Unit , 2012, Journal of health, population, and nutrition.

[110]  R. Breiman,et al.  Differing Burden and Epidemiology of Non-Typhi Salmonella Bacteremia in Rural and Urban Kenya, 2006–2009 , 2012, PloS one.

[111]  Herman Goossens,et al.  Ready for a world without antibiotics? The Pensières Antibiotic Resistance Call to Action , 2012, Antimicrobial Resistance and Infection Control.

[112]  D. Schnabel,et al.  Prevalence and antibiotic resistance of bacterial pathogens isolated from childhood diarrhoea in four provinces of Kenya. , 2012, Journal of infection in developing countries.

[113]  H. Al-Shamahy,et al.  Types of Bacteria associated with Neonatal Sepsis in Al-Thawra University Hospital, Sana'a, Yemen, and their Antimicrobial Profile. , 2012, Sultan Qaboos University medical journal.

[114]  K. Rahal,et al.  Serotyping and antibiotic susceptibility of Streptococcus pneumoniae strains isolated in Algeria from 2001 to 2010. , 2012, Medecine et maladies infectieuses.

[115]  M. Mckenna.  Vaccine development: Man vs MRSA , 2012, Nature.

[116]  Q. Bassat,et al.  Single-dose azithromycin versus benzathine benzylpenicillin for treatment of yaws in children in Papua New Guinea: an open-label, non-inferiority, randomised trial , 2012, The Lancet.

[117]  H. Goossens,et al.  Current Trends in Culture-Based and Molecular Detection of Extended-Spectrum-β-Lactamase-Harboring and Carbapenem-Resistant Enterobacteriaceae , 2012, Journal of Clinical Microbiology.

[118]  G. Kahlmeter,et al.  Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO·SENS study revisited. , 2012, International journal of antimicrobial agents.

[119]  A. Coates,et al.  Antibiotics in phase II and III clinical trials. , 2012, Handbook of experimental pharmacology.

[120]  R. Bax,et al.  Introduction to antibiotic resistance. , 2012, Handbook of experimental pharmacology.

[121]  J. E. Blanchard,et al.  A small molecule discrimination map of the antibiotic resistance kinome. , 2011, Chemistry & biology.

[122]  P. Magnussen,et al.  Antibiotic use among patients with febrile illness in a low malaria endemicity setting in Uganda , 2011, Malaria Journal.

[123]  L. Burrows,et al.  Palmitoyl‐dl‐Carnitine is a Multitarget Inhibitor of Pseudomonas aeruginosa Biofilm Development , 2011, Chembiochem : a European journal of chemical biology.

[124]  H. Goossens,et al.  Performance of Different Mono- and Multiplex Nucleic Acid Amplification Tests on a Multipathogen External Quality Assessment Panel , 2011, Journal of Clinical Microbiology.

[125]  D. Isaacs,et al.  Multi-drug resistant gram negative bacilli causing early neonatal sepsis in India , 2011, Archives of Disease in Childhood: Fetal and Neonatal Edition.

[126]  I. Rudan,et al.  Aetiology of community-acquired neonatal sepsis in low and middle income countries , 2011, Journal of global health.

[127]  A. Chiabi,et al.  The Clinical and Bacteriogical Spectrum of Neonatal Sepsis in a Tertiary Hospital in Yaounde, Cameroon , 2011, Iranian journal of pediatrics.

[128]  L. Gram,et al.  Inhibition of Virulence Gene Expression in Staphylococcus aureus by Novel Depsipeptides from a Marine Photobacterium , 2011, Marine drugs.

[129]  A. Dusé,et al.  NDM-1 has arrived: first report of a carbapenem resistance mechanism in South Africa. , 2011, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[130]  R. Laxminarayan,et al.  Communicating trends in resistance using a drug resistance index , 2011, BMJ Open.

[131]  M. Aidoo.  Divining without seeds: The case for strengthening laboratory medicine in Africa , 2011 .

[132]  H. Endtz,et al.  Bacterial aetiology of diarrhoeal diseases and antimicrobial resistance in Dhaka, Bangladesh, 2005–2008 , 2011, Epidemiology and Infection.

[133]  Yi Zhang,et al.  Advances in microfluidic PCR for point-of-care infectious disease diagnostics. , 2011, Biotechnology advances.

[134]  A. Armaganidis,et al.  Colonization and infection by colistin-resistant Gram-negative bacteria in a cohort of critically ill patients. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[135]  Y. Takeda,et al.  Genetic characteristics and changing antimicrobial resistance among Shigella spp. isolated from hospitalized diarrhoeal patients in Kolkata, India. , 2011, Journal of medical microbiology.

[136]  R. Charles,et al.  Cholera in the 21st century , 2011, Current opinion in infectious diseases.

[137]  M. Fischbach.  Combination therapies for combating antimicrobial resistance. , 2011, Current opinion in microbiology.

[138]  S. Levy,et al.  Food Animals and Antimicrobials: Impacts on Human Health , 2011, Clinical Microbiology Reviews.

[139]  N. Woodford,et al.  Prevalence of faecal carriage of Enterobacteriaceae with NDM-1 carbapenemase at military hospitals in Pakistan, and evaluation of two chromogenic media. , 2011, The Journal of antimicrobial chemotherapy.

[140]  Thierry Naas,et al.  Global Spread of Carbapenemase-producing Enterobacteriaceae , 2011, Emerging infectious diseases.

[141]  Hajo Grundmann,et al.  Mortality and Hospital Stay Associated with Resistant Staphylococcus aureus and Escherichia coli Bacteremia: Estimating the Burden of Antibiotic Resistance in Europe , 2011, PLoS medicine.

[142]  D. Revel.  W[h]ither the Kyoto Protocol? Durban and Beyond , 2011 .

[143]  R. Cantón,et al.  Emergence and spread of antibiotic resistance following exposure to antibiotics. , 2011, FEMS microbiology reviews.

[144]  I. Okeke,et al.  Non-prescription antimicrobial use worldwide: a systematic review. , 2011, The Lancet. Infectious diseases.

[145]  U. Gupta,et al.  Rationalizing antibiotic use to limit antibiotic resistance in India+ , 2011, The Indian journal of medical research.

[146]  M. Widerström,et al.  Near absence of methicillin‐resistance and pronounced genetic diversity among Staphylococcus epidermidis isolated from healthy persons in northern Sweden , 2011, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[147]  A. Levin,et al.  Role of the private sector in the provision of immunization services in low- and middle-income countries. , 2011, Health policy and planning.

[148]  E. Ashley,et al.  Antimicrobial susceptibility of bacterial isolates from community acquired infections in Sub-Saharan Africa and Asian low and middle income countries , 2011, Tropical medicine & international health : TM & IH.

[149]  Mike Tyers,et al.  Cross-species discovery of syncretic drug combinations that potentiate the antifungal fluconazole , 2011, Molecular systems biology.

[150]  M. Bonten,et al.  Dutch patients, retail chicken meat and poultry share the same ESBL genes, plasmids and strains. , 2011, Clinical Microbiology and Infection.

[151]  Mike Tyers,et al.  Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy. , 2011, Nature chemical biology.

[152]  S. Malla,et al.  Resistotypes of Vibrio cholerae 01 Ogawa Biotype El Tor in Kathmandu, Nepal. , 2011, Nepal Medical College journal : NMCJ.

[153]  A. Coates,et al.  Novel classes of antibiotics or more of the same? , 2011, British journal of pharmacology.

[154]  D. Livermore,et al.  Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. , 2011, The Lancet. Infectious diseases.

[155]  M. Raviglione,et al.  The WHO policy package to combat antimicrobial resistance. , 2011, Bulletin of the World Health Organization.

[156]  D. Shlaes,et al.  Fix the antibiotics pipeline , 2011, Nature.

[157]  A. Towse,et al.  Incentives for R&D for New Antimicrobial Drugs , 2011 .

[158]  R. Bergström.  The role of the pharmaceutical industry in meeting the public health threat of antibacterial resistance. , 2011, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[159]  J. Fernebro.  Fighting bacterial infections-future treatment options. , 2011, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[160]  I. Okeke,et al.  Diagnostics as essential tools for containing antibacterial resistance. , 2011, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[161]  Y. Carmeli,et al.  Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[162]  J Weigelt,et al.  Towards new business models for R&D for novel antibiotics. , 2011, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[163]  Ramanan Laxminarayan,et al.  A framework for global surveillance of antibiotic resistance. , 2011, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[164]  Y. Carmeli,et al.  A Call for Action: The Application of the International Health Regulations to the Global Threat of Antimicrobial Resistance , 2011, PLoS medicine.

[165]  Peter Davey,et al.  Mortality associated with in-hospital bacteraemia caused by Staphylococcus aureus: a multistate analysis with follow-up beyond hospital discharge. , 2011, The Journal of antimicrobial chemotherapy.

[166]  E. Ashley,et al.  Susceptibility of community‐acquired pathogens to antibiotics in Africa and Asia in neonates – an alarmingly short review , 2011, Tropical medicine & international health : TM & IH.

[167]  Gerard D. Wright,et al.  Antibiotic adjuvants: multicomponent anti-infective strategies , 2011, Expert Reviews in Molecular Medicine.

[168]  B. Allegranzi,et al.  Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis , 2011, The Lancet.

[169]  Z. Rahman,et al.  Retrospective Analysis of Neonatal Bacteremia and Antimicrobial Resistance Pattern in Neonatal Intensive Care Unit , 2011 .

[170]  I. Okeke.  Divining without Seeds , 2011 .

[171]  Rachel Nugent.  The Race Against Drug Resistance , 2011 .

[172]  J. Wain,et al.  Prevalent genotypes of meticillin-resistant Staphylococcus aureus: report from Pakistan. , 2011, Journal of medical microbiology.

[173]  K. Mertens,et al.  Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study. , 2011, The Lancet. Infectious diseases.

[174]  R. Peeling,et al.  Increasing access to diagnostics through technology transfer and local production , 2011 .

[175]  Sonstiges.  Corruption Perceptions Index , 2011 .

[176]  T. Bousema,et al.  Malaria diagnostic testing and treatment practices in three different Plasmodium falciparum transmission settings in Tanzania: before and after a government policy change , 2011, Malaria Journal.

[177]  M. Schapira,et al.  Newly Discovered and Characterized Antivirulence Compounds Inhibit Bacterial Mono-ADP-Ribosyltransferase Toxins , 2010, Antimicrobial Agents and Chemotherapy.

[178]  Elias Mossialos,et al.  Policies and Incentives for Promoting Innovation in Antibiotic Research , 2010 .

[179]  S. Parija,et al.  Molecular characterization of antimicrobial resistance in non-typhoidal salmonellae associated with systemic manifestations from India. , 2010, Journal of medical microbiology.

[180]  D. Maki,et al.  Impact of International Nosocomial Infection Control Consortium (INICC) Strategy on Central Line–Associated Bloodstream Infection Rates in the Intensive Care Units of 15 Developing Countries , 2010, Infection Control & Hospital Epidemiology.

[181]  U. Hayat,et al.  Neonatal sepsis: causative bacteria and their resistance to antibiotics. , 2010, Journal of Ayub Medical College, Abbottabad : JAMC.

[182]  L. Raka.  Prevention and Control of Hospital-Related Infections in Low and Middle Income Countries~!2010-02-28~!2010-05-06~!2010-09-14~! , 2010 .

[183]  L. Raka.  Prevention and Control of Hospital-Related Infections in Low and MiddleIncome Countries , 2010 .

[184]  Eduardo Gotuzzo,et al.  Rapid molecular detection of tuberculosis and rifampin resistance. , 2010, The New England journal of medicine.

[185]  A. Genovesio,et al.  High Content Phenotypic Cell-Based Visual Screen Identifies Mycobacterium tuberculosis Acyltrehalose-Containing Glycolipids Involved in Phagosome Remodeling , 2010, PLoS pathogens.

[186]  M. Koziol,et al.  Using Public Expenditure Tracking Surveys to Monitor Projects and Small-Scale Programs: A Guidebook , 2010 .

[187]  Margrith E. Mattmann,et al.  Small molecules that modulate quorum sensing and control virulence in Pseudomonas aeruginosa. , 2010, The Journal of organic chemistry.

[188]  H. Goossens,et al.  Socioeconomic determinants of outpatient antibiotic use in Europe , 2010, International Journal of Public Health.

[189]  F. Aarestrup,et al.  Changes in the use of antimicrobials and the effects on productivity of swine farms in Denmark. , 2010, American journal of veterinary research.

[190]  S. Mshana,et al.  Predictors of positive blood culture and deaths among neonates with suspected neonatal sepsis in a tertiary hospital, Mwanza- Tanzania , 2010, BMC pediatrics.

[191]  M. Asaduzzaman,et al.  Antibiotic sensitivity pattern of causative organisms of neonatal septicemia in an urban hospital of Bangladesh. , 2010, Indian journal of medical sciences.

[192]  F. Aarestrup,et al.  Microbiologic and Clinical Features of Salmonella Species Isolated From Bacteremic Children in Eastern Democratic Republic of Congo , 2010, The Pediatric infectious disease journal.

[193]  I. Okeke,et al.  When medicines fail: recommendations for curbing antibiotic resistance. , 2010, Journal of infection in developing countries.

[194]  Sania Nishtar,et al.  Choked pipes--reforming Pakistan's mixed health system. , 2010, JPMA. The Journal of the Pakistan Medical Association.

[195]  J. Cavanagh,et al.  Synergistic Effects between Conventional Antibiotics and 2-Aminoimidazole-Derived Antibiofilm Agents , 2010, Antimicrobial Agents and Chemotherapy.

[196]  Y. Teo,et al.  Typhoid in Kenya Is Associated with a Dominant Multidrug-Resistant Salmonellaenterica Serovar Typhi Haplotype That Is Also Widespread in Southeast Asia , 2010, Journal of Clinical Microbiology.

[197]  R. Gonzales,et al.  Trends in antibiotic utilization in eight Latin American countries, 1997-2007. , 2010, Revista panamericana de salud publica = Pan American journal of public health.

[198]  E. Khan,et al.  Increased isolation of ESBL producing Klebsiella pneumoniae with emergence of carbapenem resistant isolates in Pakistan: report from a tertiary care hospital. , 2010, JPMA. The Journal of the Pakistan Medical Association.

[199]  E. J. Threlfall,et al.  Reflection paper on MRSA in food-producing and companion animals: epidemiology and control options for human and animal health , 2010, Epidemiology and Infection.

[200]  R. H. Baltz,et al.  Daptomycin: from the mountain to the clinic, with essential help from Francis Tally, MD. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[201]  F. Monsma,et al.  Screening for Antibacterial Inhibitors of the UDP-3-O-(R-3-Hydroxymyristoyl)- N-Acetylglucosamine Deacetylase (LpxC) Using a High-Throughput Mass Spectrometry Assay , 2010, Journal of biomolecular screening.

[202]  R. Bonomo,et al.  Three Decades of β-Lactamase Inhibitors , 2010, Clinical Microbiology Reviews.

[203]  J. Davies,et al.  Origins and Evolution of Antibiotic Resistance , 1996, Microbiology and Molecular Biology Reviews.

[204]  B. Abera,et al.  Antimicrobial suceptibility of V. cholerae in north west, Ethiopia. , 2010, Ethiopian medical journal.

[205]  Y. Woldeamanuel,et al.  Risk factors and etiology of neonatal sepsis in Tikur Anbessa University Hospital, Ethiopia. , 2010, Ethiopian medical journal.

[206]  D. Pearl,et al.  Canadian province-level risk factor analysis of macrolide consumption patterns (2000-2006). , 2010, The Journal of antimicrobial chemotherapy.

[207]  H. Goossens,et al.  Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries. , 2010, The Lancet. Infectious diseases.

[208]  L. Raka.  Prevention and Control of Hospital-Related Infections in Low and Middle Income Countries , 2010 .

[209]  A. Zaidi,et al.  Pan-resistant Acinetobacter infection in neonates in Karachi, Pakistan. , 2010, Journal of infection in developing countries.

[210]  I. Lavi,et al.  Variability in Outpatient Antimicrobial Consumption in Israel , 2010, Infection.

[211]  K. Nielsen,et al.  Bacterial diversity in faeces from polar bear (Ursus maritimus) in Arctic Svalbard , 2010, BMC Microbiology.

[212]  S. Kariuki,et al.  Molecular characterisation of Vibrio cholerae O1 strains carrying an SXT/R391-like element from cholera outbreaks in Kenya: 1994-2007 , 2009, BMC Microbiology.

[213]  S. Ben Redjeb,et al.  Antimicrobial Resistance of Respiratory Pathogens in North African Countries , 2009, Journal of chemotherapy.

[214]  R. Gareis,et al.  Antibiotic stewardship implementation in the EU: the way forward , 2009, Expert review of anti-infective therapy.

[215]  G. Dougan,et al.  Epidemic multiple drug resistant Salmonella Typhimurium causing invasive disease in sub-Saharan Africa have a distinct genotype. , 2009, Genome research.

[216]  H. Ingmer,et al.  Method for Screening Compounds That Influence Virulence Gene Expression in Staphylococcus aureus , 2009, Antimicrobial Agents and Chemotherapy.

[217]  A. Apisarnthanarak,et al.  Comparison of Methods of Measuring Pharmacy Sales of Antibiotics without Prescriptions in Pratumthani, Thailand , 2009, Infection Control & Hospital Epidemiology.

[218]  Maureen Lewis,et al.  Governance in Health Care Delivery: Raising Performance , 2009 .

[219]  T. Cherian,et al.  Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates , 2009, The Lancet.

[220]  A. Mainous,et al.  Availability of Antibiotics for Purchase Without a Prescription on the Internet , 2009, The Annals of Family Medicine.

[221]  Sang Ho Lee,et al.  A Staphylococcus aureus fitness test platform for mechanism-based profiling of antibacterial compounds. , 2009, Chemistry & biology.

[222]  R. Hancock,et al.  Potential of immunomodulatory host defense peptides as novel anti-infectives , 2009, Trends in Biotechnology.

[223]  O. Oguntibeju,et al.  An epidemiological survey of neonatal sepsis in a hospital in western Nigeria , 2009 .

[224]  H Goossens,et al.  European Antibiotic Awareness Day, 2008 - the first Europe-wide public information campaign on prudent antibiotic use: methods and survey of activities in participating countries. , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[225]  I. Bygbjerg,et al.  Health laboratories in the Tanga region of Tanzania: the quality of diagnostic services for malaria and other communicable diseases , 2009, Annals of tropical medicine and parasitology.

[226]  H. Goossens,et al.  Variation in antibiotic prescribing and its impact on recovery in patients with acute cough in primary care: prospective study in 13 countries , 2009, BMJ : British Medical Journal.

[227]  P. Bonnabry,et al.  Temporal effects of antibiotic use and Clostridium difficile infections. , 2009, The Journal of antimicrobial chemotherapy.

[228]  N. Malik,et al.  Frequency and antimicrobial susceptibility pattern of methicillin resistant Staphylococcus aureus. , 2009, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP.

[229]  H. Tinto,et al.  Rapid malaria diagnostic tests vs. clinical management of malaria in rural Burkina Faso: safety and effect on clinical decisions. A randomized trial , 2009, Tropical medicine & international health : TM & IH.

[230]  S. Koike,et al.  Fate and transport of antibiotic residues and antibiotic resistance genes following land application of manure waste. , 2009, Journal of environmental quality.

[231]  M. Brandileone,et al.  [Resistance to non-beta-lactam antibiotics in the clinical isolates of Streptococcus pneumoniae of children in Latin America. SIREVA II, 2000-2005]. , 2009, Revista panamericana de salud publica = Pan American journal of public health.

[232]  R. Dagan.  Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[233]  J. Lynch,et al.  Streptococcus pneumoniae: Does Antimicrobial Resistance Matter? , 2009, Seminars in respiratory and critical care medicine.

[234]  M. D. Kraker,et al.  Prevalence of penicillin and erythromycin resistance among invasive Streptococcus pneumoniae isolates reported by laboratories in the southern and eastern Mediterranean region. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[235]  A. Naheed,et al.  Invasive pneumococcal disease among children in rural Bangladesh: results from a population-based surveillance. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[236]  J. Blanchard,et al.  Meropenem-Clavulanate Is Effective Against Extensively Drug-Resistant Mycobacterium tuberculosis , 2009, Science.

[237]  M. Fitch,et al.  The Centers for Medicare and Medicaid Services (CMS) community-acquired pneumonia core measures lead to unnecessary antibiotic administration by emergency physicians. , 2009, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[238]  A. Zaidi,et al.  Pathogens Associated With Sepsis in Newborns and Young Infants in Developing Countries , 2009, The Pediatric infectious disease journal.

[239]  C. Tralau-Stewart,et al.  Drug discovery: new models for industry-academic partnerships. , 2009, Drug discovery today.

[240]  J. Bartlett,et al.  Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[241]  G. Yarranton,et al.  Antibodies for the treatment of bacterial infections: current experience and future prospects. , 2008, Current opinion in biotechnology.

[242]  H. Goossens,et al.  Optimal Sampling Sites and Methods for Detection of Pathogens Possibly Causing Community-Acquired Lower Respiratory Tract Infections , 2008, Journal of Clinical Microbiology.

[243]  F. Wood,et al.  Antibiotics in the community: a typology of user behaviours. , 2008, Patient education and counseling.

[244]  M. Rizvi,et al.  Rising prevalence of enteric fever due to multidrug-resistant Salmonella: an epidemiological study. , 2008, Journal of medical microbiology.

[245]  A. So,et al.  Meeting the challenge of antibiotic resistance , 2008, BMJ : British Medical Journal.

[246]  S. Escaich.  Antivirulence as a new antibacterial approach for chemotherapy. , 2008, Current opinion in chemical biology.

[247]  J. Dushoff,et al.  Antibiotic overuse: the influence of social norms. , 2008, Journal of the American College of Surgeons.

[248]  A. Apisarnthanarak,et al.  Nonjudicious Dispensing of Antibiotics by Drug Stores in Pratumthani, Thailand , 2008, Infection Control & Hospital Epidemiology.

[249]  J. Burgerhof,et al.  Determinants of self-medication with antibiotics in Europe: the impact of beliefs, country wealth and the healthcare system. , 2008, The Journal of antimicrobial chemotherapy.

[250]  M. Molyneux,et al.  Epidemics of invasive Salmonella enterica serovar enteritidis and S. enterica Serovar typhimurium infection associated with multidrug resistance among adults and children in Malawi. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[251]  T. Stijnen,et al.  Rapid identification and antimicrobial susceptibility testing reduce antibiotic use and accelerate pathogen-directed antibiotic use. , 2007, The Journal of antimicrobial chemotherapy.

[252]  E. Khan,et al.  Antibiotic susceptibility of pathogens isolated from patients with community-acquired respiratory tract infections in Pakistan--the active study. , 2008, Journal of Ayub Medical College, Abbottabad : JAMC.

[253]  T. Lauderdale,et al.  Competing Doctors , Antibiotic Use , and Antibiotic Resistance in Taiwan ∗ , 2008 .

[254]  J. Wierzbowski,et al.  Combination drugs, an emerging option for antibacterial therapy. , 2007, Trends in biotechnology.

[255]  David L. Smith,et al.  Hospitalizations and Deaths Caused by Methicillin-Resistant Staphylococcus aureus, United States, 1999–2005 , 2007, Emerging infectious diseases.

[256]  R. Adegbola,et al.  Molecular epidemiology of community-acquired invasive non-typhoidal Salmonella among children aged 2 29 months in rural Gambia and discovery of a new serovar, Salmonella enterica Dingiri. , 2007, Journal of medical microbiology.

[257]  K. Ko,et al.  High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea. , 2007, The Journal of antimicrobial chemotherapy.

[258]  M. Planta.  The Role of Poverty in Antimicrobial Resistance , 2007, The Journal of the American Board of Family Medicine.

[259]  Roberta B Carey,et al.  Invasive methicillin-resistant Staphylococcus aureus infections in the United States. , 2007, JAMA.

[260]  F. Aarestrup,et al.  The attribution of human infections with antimicrobial resistant Salmonella bacteria in Denmark to sources of animal origin. , 2007, Foodborne pathogens and disease.

[261]  J. Burke,et al.  Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[262]  S. Harthug,et al.  Antimicrobial resistance predicts death in Tanzanian children with bloodstream infections: a prospective cohort study , 2007, BMC infectious diseases.

[263]  A. Armaganidis,et al.  Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster. , 2007, The Journal of antimicrobial chemotherapy.

[264]  P. Menéndez,et al.  The contribution of oxazolidinone frame to the biological activity of pharmaceutical drugs and natural products. , 2007, Mini reviews in medicinal chemistry.

[265]  R. Laxminarayan.  Extending the Cure: Policy Responses to the Growing Threat of Antibiotic Resistance , 2007 .

[266]  S. Müller,et al.  Small-Molecule Inhibitor of Vibrio cholerae Virulence and Intestinal Colonization , 2007 .

[267]  D. Pompliano,et al.  Drugs for bad bugs: confronting the challenges of antibacterial discovery , 2007, Nature Reviews Drug Discovery.

[268]  S. Kariuki,et al.  Characterisation of community acquired non-typhoidal Salmonella from bacteraemia and diarrhoeal infections in children admitted to hospital in Nairobi, Kenya , 2006, BMC Microbiology.

[269]  R. Hancock,et al.  Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies , 2006, Nature Biotechnology.

[270]  G. Nair,et al.  Multiply antibiotic-resistant Vibrio cholerae O1 biotype El Tor strains emerge during cholera outbreaks in Zambia , 2006, Epidemiology and Infection.

[271]  Yee-Wei Lim,et al.  Reducing the global burden of acute lower respiratory infections in children: the contribution of new diagnostics , 2006, Nature.

[272]  J. Bartlett.  Narrative Review: The New Epidemic of Clostridium difficileAssociated Enteric Disease , 2006, Annals of Internal Medicine.

[273]  Thorkild Tylleskär,et al.  Bacteraemia among severely malnourished children infected and uninfected with the human immunodeficiency virus-1 in Kampala, Uganda , 2006, BMC infectious diseases.

[274]  M. Filippini,et al.  Socioeconomic determinants of regional differences in outpatient antibiotic consumption: evidence from Switzerland. , 2006, Health policy.

[275]  V. Jensen,et al.  Usage of veterinary therapeutic antimicrobials in Denmark, Norway and Sweden following termination of antimicrobial growth promoter use. , 2006, Preventive veterinary medicine.

[276]  Sheila K West,et al.  Field evaluation of a rapid point-of-care assay for targeting antibiotic treatment for trachoma control: a comparative study , 2006, The Lancet.

[277]  Nadine H. Elowe,et al.  An in vitro screen of bacterial lipopolysaccharide biosynthetic enzymes identifies an inhibitor of ADP-heptose biosynthesis. , 2006, Chemistry & biology.

[278]  L. Mcfarland.  Meta-Analysis of Probiotics for the Prevention of Antibiotic Associated Diarrhea and the Treatment of Clostridium difficile Disease , 2006, The American Journal of Gastroenterology.

[279]  K. Bostian,et al.  Practical applications and feasibility of efflux pump inhibitors in the clinic--a vision for applied use. , 2006, Biochemical pharmacology.

[280]  H. Goossens,et al.  Two Quality Control Exercises Involving Nucleic Acid Amplification Methods for Detection of Mycoplasma pneumoniae and Chlamydophila pneumoniae and Carried Out 2 Years Apart (in 2002 and 2004) , 2006, Journal of Clinical Microbiology.

[281]  Dominique L. Monnet,et al.  In Vivo Transfer of the vanA Resistance Gene from an Enterococcus faecium Isolate of Animal Origin to an E. faecium Isolate of Human Origin in the Intestines of Human Volunteers , 2006, Antimicrobial Agents and Chemotherapy.

[282]  David L Paterson,et al.  The role of antimicrobial management programs in optimizing antibiotic prescribing within hospitals. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[283]  P. Doró,et al.  Regional variations in community consumption of antibiotics in Hungary, 1996-2003. , 2006, British journal of clinical pharmacology.

[284]  F. Mahoney,et al.  Population-based surveillance of typhoid fever in Egypt. , 2006, The American journal of tropical medicine and hygiene.

[285]  Rosanna W Peeling,et al.  A guide for diagnostic evaluations , 2006, Nature Reviews Microbiology.

[286]  K. Mani,et al.  Prevalence and antimicrobial susceptibility pattern of methicillin resistant Staphylococcus aureus: a multicentre study. , 2006, Indian journal of medical microbiology.

[287]  S. Michie,et al.  Interventions to improve antibiotic prescribing practices for hospital inpatients. , 2017, The Cochrane database of systematic reviews.

[288]  Conan MacDougall,et al.  Antimicrobial Stewardship Programs in Health Care Systems , 2005, Clinical Microbiology Reviews.

[289]  I. Okeke,et al.  Antimicrobial resistance in developing countries. Part II: strategies for containment. , 2005, The Lancet. Infectious diseases.

[290]  Ramanan Laxminarayan,et al.  Antimicrobial resistance in developing countries. Part I: recent trends and current status. , 2005, The Lancet. Infectious diseases.

[291]  K. Holmes,et al.  History of U.S. military contributions to the study of sexually transmitted diseases. , 2005, Military medicine.

[292]  Z. Bhutta,et al.  Hospital-acquired neonatal infections in developing countries , 2005, The Lancet.

[293]  P. Hergenrother,et al.  Bacterial death comes full circle: targeting plasmid replication in drug-resistant bacteria. , 2005, Organic & biomolecular chemistry.

[294]  H. Goossens,et al.  Outpatient antibiotic use in Europe and association with resistance: a cross-national database study , 2005, The Lancet.

[295]  D. Cardo,et al.  Implementation of the Campaign to Prevent Antimicrobial Resistance in Healthcare Settings: 12 Steps to Prevent Antimicrobial Resistance Among Hospitalized Adults--experiences from 3 institutions. , 2005, American journal of infection control.

[296]  D. Byarugaba.  Antimicrobial Resistance and its Containment in Developing Countries , 2005 .

[297]  János Bérdy,et al.  Bioactive microbial metabolites. , 2005, The Journal of antibiotics.

[298]  L. Hazlehurst,et al.  Drug Resistance , 2004 .

[299]  Sharon S. Choi,et al.  Implementing electronic medical record systems in developing countries. , 2005, Informatics in primary care.

[300]  R. Black,et al.  Zinc therapy for diarrhoea increased the use of oral rehydration therapy and reduced the use of antibiotics in Bangladeshi children. , 2004, Journal of health, population, and nutrition.

[301]  D. Byarugaba.  A view on antimicrobial resistance in developing countries and responsible risk factors. , 2004, International journal of antimicrobial agents.

[302]  Jean-Pierre Habicht,et al.  Improving antimicrobial use among health workers in first-level facilities: results from the multi-country evaluation of the Integrated Management of Childhood Illness strategy. , 2004, Bulletin of the World Health Organization.

[303]  R. Nugent.  Food and Agriculture Policy: Issues Related to Prevention of Noncommunicable Diseases , 2004, Food and nutrition bulletin.

[304]  O. Rutschmann,et al.  Antibiotics for upper respiratory tract infections in ambulatory practice in the United States, 1997-1999: does physician specialty matter? , 2004, The Journal of the American Board of Family Practice.

[305]  G. Burnham,et al.  Economic evaluation of Mectizan distribution , 2004, Tropical medicine & international health : TM & IH.

[306]  Col Perks,et al.  A Case for Change , 2004 .

[307]  J. Powers.  Antimicrobial drug development--the past, the present, and the future. , 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[308]  M. Oh,et al.  Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[309]  Robert M Siegel,et al.  Treatment of otitis media with observation and a safety-net antibiotic prescription. , 2003, Pediatrics.

[310]  Aryanti Radyowijati,et al.  Improving antibiotic use in low-income countries: an overview of evidence on determinants. , 2003, Social science & medicine.

[311]  Ralph Gonzales,et al.  Predictors of broad-spectrum antibiotic prescribing for acute respiratory tract infections in adult primary care. , 2003, JAMA.

[312]  R. Laxminarayan.  Battling resistance to antibiotics and pesticides: an economic approach. , 2003 .

[313]  B. M. Sharma,et al.  Prevalence of methicillin resistant Staphylococcus aureus in a tertiary referral hospital in eastern Uttar Pradesh. , 2003, Indian journal of medical microbiology.

[314]  S. Crupper,et al.  Molecular characterization of antibiotic resistance in clinical Salmonella typhi isolated in Ghana. , 2002, FEMS microbiology letters.

[315]  T. O'Brien.  Emergence, spread, and environmental effect of antimicrobial resistance: how use of an antimicrobial anywhere can increase resistance to any antimicrobial anywhere else. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[316]  David L. Smith,et al.  Animal antibiotic use has an early but important impact on the emergence of antibiotic resistance in human commensal bacteria , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[317]  R. Wise.  Antimicrobial resistance: priorities for action. , 2002, The Journal of antimicrobial chemotherapy.

[318]  P. Mackowiak.  Complicated Urinary Tract Infection in a Diabetic Woman , 2002 .

[319]  H Aggarwal,et al.  Improving inpatient antibiotic prescribing: insights from participation in a national collaborative. , 2001, The Joint Commission journal on quality improvement.

[320]  J. Sturchio.  The case of ivermectin: lessons and implications for improving access to care and treatment in developing countries. , 2001, Community eye health.

[321]  W. Witte,et al.  Selective pressure by antibiotic use in livestock. , 2000, International journal of antimicrobial agents.

[322]  G. Malenga,et al.  Salmonella meningitis in children in Blantyre, Malawi, 1996–1999 , 2000, Annals of tropical paediatrics.

[323]  F. R. Sánchez,et al.  Empleo racional de los antibióticos en pediatría: impacto de la aplicación de un test rápido de detección de estreptococo beta-hemolítico del grupo A en la faringoamigdalitis aguda , 2000 .

[324]  É. Chaslus-Dancla,et al.  Spread of resistance from food animals to man: the French experience. , 2000, Acta veterinaria Scandinavica. Supplementum.

[325]  F. Rodríguez Sánchez,et al.  [Rational use of antibiotics in pediatrics: impact of a rapid test for detection of beta-haemolytic group A streptococci in acute pharyngotonsillitis]. , 2000, Anales espanoles de pediatria.

[326]  U. Raman,et al.  Community Eye Health , 2004 .

[327]  V. Diwan,et al.  Association between health insurance and antibiotics prescribing in four counties in rural China. , 1999, Health policy.

[328]  I. Okeke,et al.  Antimicrobial resistance in developing countries , 1998, BMJ.

[329]  C M Kilo,et al.  A Framework for Collaborative Improvement: Lessons from the Institute for Healthcare Improvement's Breakthrough Series , 1998, Quality management in health care.

[330]  H. Sørum,et al.  Transfer of multiple drug resistance plasmids between bacteria of diverse origins in natural microenvironments , 1994, Applied and environmental microbiology.

[331]  D. Jamison,et al.  Disease Control Priorities in Developing Countries , 1993 .

[332]  S. Solomon,et al.  Health and economic impacts of antimicrobial resistance. , 1987, Reviews of infectious diseases.

[333]  S. Holmberg,et al.  Drug-resistant Salmonella from animals fed antimicrobials. , 1984, The New England journal of medicine.

[334]  S. Levy,et al.  Spread of antibiotic-resistant plasmids from chicken to chicken and from chicken to man , 1976, Nature.

[335]  F. V. Potapnev.  [Gonorrhea in men]. , 1975, Meditsinskaia sestra.

[336]  Kunin Cm.  This is medical progress? Trends and consequences of antibiotic use in the United States. In comment. , 1974 .

[337]  P. Stolley,et al.  This is medical progress? Trends and consequences of antibiotic use in the United States. , 1974, JAMA.

[338]  K. Holmes,et al.  Studies of venereal disease. I. Probenecid-procaine penicillin G combination and tetracycline hydrochloride in the treatment of "penicillin-resistant" gonorrhea in men. , 1967, JAMA.

[339]  P. Robinson.  CONTROLLED TRIAL OF AUREOMYCIN IN PREMATURE TWINS AND TRIPLETS , 1952 .

[340]  T. Jukes,et al.  Further Observations on the “Animal Protein Factor” , 1950 .

[341]  M. Tager,et al.  Penicillin, Its Practical Application , 1946, The Yale Journal of Biology and Medicine.

[342]  E. Abraham,et al.  An Enzyme from Bacteria able to Destroy Penicillin , 1940, Nature.